Blogs

Request a Technical Expert

Discuss your application, testing objectives, project requirements with a PTI technical expert

Expert Guidance
Application Discussion
Quick Response
03
Oct 2026

How Does Leak Rate Relate to Leak Size in Pharmaceutical CCIT?

How-Does-Leak-Rate-Relate-to-Leak-Size-in-Pharmaceutical-ccit

Leak rate and leak size are important parameters in pharmaceutical container closure integrity testing (CCIT), but they describe different characteristics of a package defect. Understanding their relationship helps manufacturers evaluate package integrity, establish appropriate acceptance criteria, and select reliable leak detection technologies.

What Is the Difference Between Leak Rate and Leak Size?

Leak size describes the physical dimensions and geometry of a defect, while leak rate measures the amount of gas or liquid passing through it under specified conditions.

In pharmaceutical packaging, defects can occur in glass vials, prefilled syringes, cartridges, ampoules, and package seals. Their physical characteristics influence leakage, but the dimensions alone do not determine how much material passes through.

  • Leak size: The dimensions and geometry of a defect, such as a pinhole, crack, or channel.
  • Leak rate: The quantity of gas or liquid passing through a defect over time, measured using units appropriate to the test method.
  • Maximum allowable leakage limit (MALL): A scientifically justified leakage limit used to evaluate whether a container closure system meets its integrity requirements.

These parameters serve different purposes. Defect size helps characterize the physical pathway, while leak rate provides information about leakage under defined conditions.

How Does Leak Size Influence Leak Rate?

Larger defects generally permit greater flow when other conditions remain comparable. However, the relationship is not universally linear because defect geometry, pressure differential, and fluid properties also influence leakage.

For example, two defects with similar diameters may produce different leak rates if one has a short, straight pathway and the other has a longer, irregular channel. Gas flow may also vary depending on the pressure regime and the dimensions of the pathway.

A study published in the PDA Journal of Pharmaceutical Science and Technology examined helium leakage through laser-drilled microholes and wire-created pathways in pharmaceutical vial and closure systems. The findings demonstrated that the relationship between leak rate and defect dimensions depends on the type of defect.

How does leak rate relate to leak size in pharmaceutical CCIT? Leak rate generally increases as defect size increases under comparable conditions. However, the relationship depends on defect geometry, pressure differential, and fluid properties. Leak rate cannot be reliably predicted from defect diameter alone without an appropriate model or experimentally established correlation.

What Factors Affect the Relationship Between Leak Rate and Leak Size?

The relationship depends on the physical characteristics of the defect and the conditions under which leakage is measured.

Factor Influence on leakage
Defect geometry Diameter, pathway length, and shape affect flow resistance.
Pressure differential Influences the driving force for gas or liquid flow.
Fluid properties Viscosity, compressibility, and other properties affect flow behaviour.
Package characteristics Headspace volume and material flexibility can influence the measured response.
Test parameters Pressure, temperature, duration, and instrument sensitivity affect detection capability.

These variables are important when establishing a correlation between reference defects and measured test responses. A correlation developed for one package configuration should not automatically be applied to another without supporting evidence.

How Do Deterministic CCIT Methods Evaluate Package Leakage?

Deterministic CCIT methods assess package integrity through measurable physical responses. Each method uses a different measurement principle, so the results must be interpreted according to the technology and its validated application.

Method Measurement principle Application
Vacuum decay Measures pressure changes in a sealed test chamber under vacuum. Non-destructive testing of suitable rigid, semi-rigid, and flexible packages.
High Voltage Leak Detection (HVLD) Detects electrical changes associated with conductive leak pathways. Suitable liquid-filled pharmaceutical containers.
Helium leak detection Measures escaping helium tracer gas. Quantitative tracer-gas leakage measurement and defect characterization.

Vacuum decay provides quantitative pressure-response data associated with leakage, while helium leak detection can quantify tracer-gas leak rates. HVLD detects electrical responses rather than directly measuring gas flow.

These methods are complementary, not interchangeable. Their suitability depends on the package format, product characteristics, critical defect, and required detection capability.

How Does PTI Relate Leak Rate Measurements to Package Integrity?

PTI (Packaging Technologies & Inspection) provides deterministic inspection technologies that help pharmaceutical manufacturers evaluate package integrity using objective, quantitative test data.

VeriPac Vacuum Decay uses pressure measurements to detect leakage non-destructively. A package is placed in a suitably designed test chamber, and vacuum is applied. Changes in absolute or differential pressure during a defined test period can indicate leakage.

PTI's VeriPac systems provide quantitative results and pass/fail determinations. The test method is described in ASTM F2338, which is recognized by the FDA as a consensus standard for package integrity testing and referenced in USP General Chapter <1207>. PTI's technology information also describes quantitative data that can correlate with leak rate and leak size when supported by the appropriate application-specific test setup.

For applications requiring tracer-gas measurements, Helium Leak Detection offers a different approach to quantifying leakage. HVLD is designed for suitable liquid-filled pharmaceutical containers where electrical changes associated with conductive leak pathways can be detected.

The appropriate method should be selected according to the package, product, and testing objective. Validation must demonstrate that the method can detect defects relevant to the container closure system's integrity requirements.

How Do USP <1207> and ASTM F2338 Support Leak Testing?

USP General Chapter <1207> provides guidance on container closure integrity evaluation for sterile pharmaceutical products. ASTM F2338 describes non-destructive leak detection using vacuum decay.

These references support science-based method selection and validation. Manufacturers should establish relevant acceptance criteria, evaluate method sensitivity, and demonstrate suitability for the intended container closure system.

The objective is to identify defects that could compromise product integrity, not simply to detect the smallest possible physical opening.

Conclusion

Leak size describes the physical defect, while leak rate quantifies leakage under specified conditions. Because their relationship depends on defect geometry and test parameters, reliable CCIT requires appropriate methods and validated correlations. PTI's deterministic technologies support different package testing requirements, helping pharmaceutical manufacturers make informed decisions about container closure integrity.

Frequently Asked Questions

1. Can two defects of the same size have different leak rates?

Yes. Differences in pathway geometry, length, pressure conditions, and fluid properties can produce different leak rates even when defects have similar opening diameters.

2. Which CCIT method measures leak rate quantitatively?

Helium leak detection can quantify tracer-gas leakage directly. Vacuum decay provides quantitative pressure-response data associated with leakage, while HVLD detects electrical changes associated with conductive pathways.

3. What is the difference between leak rate and MALL?

Leak rate is a measured quantity under specified conditions. MALL is the scientifically justified leakage limit used to evaluate whether a container closure system meets its integrity requirements.

4. Why is leak-rate characterization important in pharmaceutical packaging?

It helps manufacturers characterize leakage, evaluate test-method performance, and establish whether a package meets its defined integrity requirements.

Readmore...
ccit, package integrity testing, container closure integrity testing, cci technologies
16

Popular Blogs

Tags

GMP Annex 1 - How the Revision Impacts Pharmaceutical Manufacturers

Aug 21, 2023   |   25549

Stay ahead in pharmaceutical manufacturing excellence! Explore the transformative changes brought by the revised Annex 1 of EU GMP guidelines. Enhance your understanding of contamination control, quality risk management, and sterile manufacturing techniques. Learn how to implement these changes effectively and ensure product quality, safety, and efficacy.

Decoding USP Standards - An In-Depth Look at USP <382>

Aug 02, 2024   |   23111

USP <382> sets new standards for assessing the functionality of elastomeric components in injectable drug packaging, emphasizing comprehensive container closure integrity testing to ensure safety and efficacy. Compliance by December 2025 is critical for pharmaceutical companies to maintain robust and reliable packaging systems.

Understanding Pressure Decay Leak Testing

Jun 07, 2021   |   23029

Pressure Decay leak test is a sensitive leak detection method particulary for testing small leaks. It is applicable across multiple industries like pharmaceutical, medical device and food and nutrition industries.

How to Leak Test High Risk Medical Device Packages

Jan 25, 2022   |   20321

Medical device leak testing is considered a critical step in ensuring package integrity primarily due to its sensitive nature. Leaks in the device can cause serious health risks to the patients and result in huge financial losses to the manufacturer. PTI's Seal-Scan technology is a non-destructive seal quality inspection technique for high risk pharmaceuticals and medical devices.

A Closer Look at PTI's Advanced Testing Services

Jun 27, 2024   |   20185

PTI offers advanced lab testing services across industries, safeguarding product integrity, safety, and regulatory adherence. Their expertise spans feasibility studies, test method development, stability testing, recall & batch release, and helium testing, all conducted by qualified professionals using advanced technologies.
Popup